Pulmonx (LUNG) Form 3: COO/CFO reports 135,319 common shares

Q: Who is the reporting person in Pulmonx’s (LUNG) Form 3?

The reporting person is Derrick Sung, the company’s COO and CFO.

Q: How many Pulmonx (LUNG) shares does the executive directly own?

He directly owns 135,319 shares of Common Stock.

Q: What is the Date of Event for this Form 3?

The Date of Event is 11/03/2025.

Q: Is this filing made by multiple reporting persons?

No. It states Form filed by One Reporting Person.

Pulmonx Corporation (LUNG) reported insider ownership via a Form 3.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Pulmonx Corporation (LUNG) reported insider ownership via a Form 3. Executive Derrick Sung, who serves as COO and CFO, disclosed 135,319 shares of Common Stock held directly. The filing lists the Date of Event as 11/03/2025. No derivative securities were reported in Table II.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sung Derrick

Role COO and CFO

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 135,319 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Pulmonx (LUNG) disclose in this Form 3?

An executive, Derrick Sung (COO and CFO), reported direct ownership of 135,319 shares of Common Stock.

Who is the reporting person in Pulmonx’s (LUNG) Form 3?

The reporting person is Derrick Sung, the company’s COO and CFO.

How many Pulmonx (LUNG) shares does the executive directly own?

He directly owns 135,319 shares of Common Stock.

Were any derivative securities reported in this filing?

No. Table II shows no derivative securities reported.

What is the Date of Event for this Form 3?

The Date of Event is 11/03/2025.

Is this filing made by multiple reporting persons?

No. It states Form filed by One Reporting Person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 11/10/2025 - 05:42 PM EST

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Sung Derrick

(Last)

(First)

(Middle)

C/O PULMONX CORPORATION

700 CHESAPEAKE DRIVE

(Street)

REDWOOD CITY

94063

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/03/2025

3. Issuer Name and Ticker or Trading Symbol
Pulmonx Corp [ LUNG ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	COO and CFO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	135,319	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

	/s/ Derrick Sung	11/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR